Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma
© 2023. Crown..
The transcription factor STAT6 (Signal Transducer and Activator of Transcription 6) is a key regulator of Th2 (T-helper 2) mediated allergic inflammation via the IL-4 (interleukin-4) JAK (Janus kinase)/STAT signalling pathway. We identified a novel heterozygous germline mutation STAT6 c.1255G > C, p.D419H leading to overactivity of IL-4 JAK/STAT signalling pathway, in a kindred affected by early-onset atopic dermatitis, food allergy, eosinophilic asthma, anaphylaxis and follicular lymphoma. STAT6 D419H expression and functional activity were compared with wild type STAT6 in transduced HEK293T cells and to healthy control primary skin fibroblasts and peripheral blood mononuclear cells (PBMC). We observed consistently higher STAT6 levels at baseline and higher STAT6 and phosphorylated STAT6 following IL-4 stimulation in D419H cell lines and primary cells compared to wild type controls. The pSTAT6/STAT6 ratios were unchanged between D419H and control cells suggesting that elevated pSTAT6 levels resulted from higher total basal STAT6 expression. The selective JAK1/JAK2 inhibitor ruxolitinib reduced pSTAT6 levels in D419H HEK293T cells and patient PBMC. Nuclear staining demonstrated increased STAT6 in patient fibroblasts at baseline and both STAT6 and pSTAT6 after IL-4 stimulation. We also observed higher transcriptional upregulation of downstream genes (XBP1 and EPAS1) in patient PBMC. Our study confirms STAT6 gain of function (GOF) as a novel monogenetic cause of early onset atopic disease. The clinical association of lymphoma in our kindred, along with previous data linking somatic STAT6 D419H mutations to follicular lymphoma suggest that patients with STAT6 GOF disease may be at higher risk of lymphomagenesis.245 words.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 43(2023), 7 vom: 17. Okt., Seite 1611-1622 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Minskaia, Ekaterina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
207137-56-2 |
|---|
| Anmerkungen: |
Date Completed 14.09.2023 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10875-023-01530-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358183677 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358183677 | ||
| 003 | DE-627 | ||
| 005 | 20240313233501.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-023-01530-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM358183677 | ||
| 035 | |a (NLM)37316763 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Minskaia, Ekaterina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.09.2023 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Crown. | ||
| 520 | |a The transcription factor STAT6 (Signal Transducer and Activator of Transcription 6) is a key regulator of Th2 (T-helper 2) mediated allergic inflammation via the IL-4 (interleukin-4) JAK (Janus kinase)/STAT signalling pathway. We identified a novel heterozygous germline mutation STAT6 c.1255G > C, p.D419H leading to overactivity of IL-4 JAK/STAT signalling pathway, in a kindred affected by early-onset atopic dermatitis, food allergy, eosinophilic asthma, anaphylaxis and follicular lymphoma. STAT6 D419H expression and functional activity were compared with wild type STAT6 in transduced HEK293T cells and to healthy control primary skin fibroblasts and peripheral blood mononuclear cells (PBMC). We observed consistently higher STAT6 levels at baseline and higher STAT6 and phosphorylated STAT6 following IL-4 stimulation in D419H cell lines and primary cells compared to wild type controls. The pSTAT6/STAT6 ratios were unchanged between D419H and control cells suggesting that elevated pSTAT6 levels resulted from higher total basal STAT6 expression. The selective JAK1/JAK2 inhibitor ruxolitinib reduced pSTAT6 levels in D419H HEK293T cells and patient PBMC. Nuclear staining demonstrated increased STAT6 in patient fibroblasts at baseline and both STAT6 and pSTAT6 after IL-4 stimulation. We also observed higher transcriptional upregulation of downstream genes (XBP1 and EPAS1) in patient PBMC. Our study confirms STAT6 gain of function (GOF) as a novel monogenetic cause of early onset atopic disease. The clinical association of lymphoma in our kindred, along with previous data linking somatic STAT6 D419H mutations to follicular lymphoma suggest that patients with STAT6 GOF disease may be at higher risk of lymphomagenesis.245 words | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Atopy | |
| 650 | 4 | |a Gain-of-function | |
| 650 | 4 | |a Lymphoma | |
| 650 | 4 | |a STAT6 | |
| 650 | 7 | |a Interleukin-4 |2 NLM | |
| 650 | 7 | |a 207137-56-2 |2 NLM | |
| 650 | 7 | |a STAT6 Transcription Factor |2 NLM | |
| 650 | 7 | |a Janus Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.10.2 |2 NLM | |
| 650 | 7 | |a STAT6 protein, human |2 NLM | |
| 700 | 1 | |a Maimaris, Jesmeen |e verfasserin |4 aut | |
| 700 | 1 | |a Jenkins, Persephone |e verfasserin |4 aut | |
| 700 | 1 | |a Albuquerque, Adriana S |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Eleftheriou, Despina |e verfasserin |4 aut | |
| 700 | 1 | |a Gilmour, Kimberly C |e verfasserin |4 aut | |
| 700 | 1 | |a Grace, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Moreira, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Grimbacher, Bodo |e verfasserin |4 aut | |
| 700 | 0 | |a NIHR Bioresource-Rare Diseases Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Emma C |e verfasserin |4 aut | |
| 700 | 1 | |a Burns, Siobhan O |e verfasserin |4 aut | |
| 700 | 1 | |a Adhya, Zoe |e investigator |4 oth | |
| 700 | 1 | |a Alachkar, Hana |e investigator |4 oth | |
| 700 | 1 | |a Anantharachagan, Ariharan |e investigator |4 oth | |
| 700 | 1 | |a Antrobus, Richard |e investigator |4 oth | |
| 700 | 1 | |a Arumugakani, Gururaj |e investigator |4 oth | |
| 700 | 1 | |a Bacchelli, Chiara |e investigator |4 oth | |
| 700 | 1 | |a Baxendale, Helen |e investigator |4 oth | |
| 700 | 1 | |a Bethune, Claire |e investigator |4 oth | |
| 700 | 1 | |a Bibi, Shahnaz |e investigator |4 oth | |
| 700 | 1 | |a Boardman, Barbara |e investigator |4 oth | |
| 700 | 1 | |a Booth, Claire |e investigator |4 oth | |
| 700 | 1 | |a Browning, Michael |e investigator |4 oth | |
| 700 | 1 | |a Brownlie, Mary |e investigator |4 oth | |
| 700 | 1 | |a Burns, Siobhan |e investigator |4 oth | |
| 700 | 1 | |a Chandra, Anita |e investigator |4 oth | |
| 700 | 1 | |a Clifford, Hayley |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Nichola |e investigator |4 oth | |
| 700 | 1 | |a Davies, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Dempster, John |e investigator |4 oth | |
| 700 | 1 | |a Devlin, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Doffinger, Rainer |e investigator |4 oth | |
| 700 | 1 | |a Drewe, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Edgar, David |e investigator |4 oth | |
| 700 | 1 | |a Egner, William |e investigator |4 oth | |
| 700 | 1 | |a El-Shanawany, Tariq |e investigator |4 oth | |
| 700 | 1 | |a Gaspar, Bobby |e investigator |4 oth | |
| 700 | 1 | |a Ghurye, Rohit |e investigator |4 oth | |
| 700 | 1 | |a Gilmour, Kimberley |e investigator |4 oth | |
| 700 | 1 | |a Goddard, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Gordins, Pavel |e investigator |4 oth | |
| 700 | 1 | |a Grigoriadou, Sofia |e investigator |4 oth | |
| 700 | 1 | |a Hackett, Scott |e investigator |4 oth | |
| 700 | 1 | |a Hague, Rosie |e investigator |4 oth | |
| 700 | 1 | |a Harper, Lorraine |e investigator |4 oth | |
| 700 | 1 | |a Hayman, Grant |e investigator |4 oth | |
| 700 | 1 | |a Herwadkar, Archana |e investigator |4 oth | |
| 700 | 1 | |a Hughes, Stephen |e investigator |4 oth | |
| 700 | 1 | |a Huissoon, Aarnoud |e investigator |4 oth | |
| 700 | 1 | |a Jolles, Stephen |e investigator |4 oth | |
| 700 | 1 | |a Jones, Julie |e investigator |4 oth | |
| 700 | 1 | |a Kelleher, Peter |e investigator |4 oth | |
| 700 | 1 | |a Klein, Nigel |e investigator |4 oth | |
| 700 | 1 | |a Kuijpers, Taco |e investigator |4 oth | |
| 700 | 1 | |a Kumararatne, Dinakantha |e investigator |4 oth | |
| 700 | 1 | |a Laffan, James |e investigator |4 oth | |
| 700 | 1 | |a Allen, Hana Lango |e investigator |4 oth | |
| 700 | 1 | |a Lear, Sara |e investigator |4 oth | |
| 700 | 1 | |a Longhurst, Hilary |e investigator |4 oth | |
| 700 | 1 | |a Lorenzo, Lorena |e investigator |4 oth | |
| 700 | 1 | |a Maimaris, Jesmeen |e investigator |4 oth | |
| 700 | 1 | |a Manson, Ania |e investigator |4 oth | |
| 700 | 1 | |a McDermott, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Millar, Hazel |e investigator |4 oth | |
| 700 | 1 | |a Mistry, Anoop |e investigator |4 oth | |
| 700 | 1 | |a Morrisson, Valerie |e investigator |4 oth | |
| 700 | 1 | |a Murng, Sai |e investigator |4 oth | |
| 700 | 1 | |a Nasir, Iman |e investigator |4 oth | |
| 700 | 1 | |a Nejentsev, Sergey |e investigator |4 oth | |
| 700 | 1 | |a Noorani, Sadia |e investigator |4 oth | |
| 700 | 1 | |a Oksenhendler, Eric |e investigator |4 oth | |
| 700 | 1 | |a Ponsford, Mark |e investigator |4 oth | |
| 700 | 1 | |a Qasim, Waseem |e investigator |4 oth | |
| 700 | 1 | |a Quinn, Ellen |e investigator |4 oth | |
| 700 | 1 | |a Quinti, Isabella |e investigator |4 oth | |
| 700 | 1 | |a Richter, Alex |e investigator |4 oth | |
| 700 | 1 | |a Samarghitean, Crina |e investigator |4 oth | |
| 700 | 1 | |a Sargur, Ravishankar |e investigator |4 oth | |
| 700 | 1 | |a Savic, Sinisa |e investigator |4 oth | |
| 700 | 1 | |a Seneviratne, Suranjith |e investigator |4 oth | |
| 700 | 1 | |a Sewall, Carrock |e investigator |4 oth | |
| 700 | 1 | |a Shackley, Fiona |e investigator |4 oth | |
| 700 | 1 | |a Simeoni, Ilenia |e investigator |4 oth | |
| 700 | 1 | |a Smith, Kenneth G C |e investigator |4 oth | |
| 700 | 1 | |a Staples, Emily |e investigator |4 oth | |
| 700 | 1 | |a Stauss, Hans |e investigator |4 oth | |
| 700 | 1 | |a Steele, Cathal |e investigator |4 oth | |
| 700 | 1 | |a Thaventhiran, James |e investigator |4 oth | |
| 700 | 1 | |a Thomas, Moira |e investigator |4 oth | |
| 700 | 1 | |a Thrasher, Adrian |e investigator |4 oth | |
| 700 | 1 | |a Welch, Steve |e investigator |4 oth | |
| 700 | 1 | |a Willcocks, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Workman, Sarita |e investigator |4 oth | |
| 700 | 1 | |a Worth, Austen |e investigator |4 oth | |
| 700 | 1 | |a Yeatman, Nigel |e investigator |4 oth | |
| 700 | 1 | |a Yong, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Ashford, Sofie |e investigator |4 oth | |
| 700 | 1 | |a Bradley, John |e investigator |4 oth | |
| 700 | 1 | |a Fletcher, Debra |e investigator |4 oth | |
| 700 | 1 | |a Hammerton, Tracey |e investigator |4 oth | |
| 700 | 1 | |a James, Roger |e investigator |4 oth | |
| 700 | 1 | |a Kingston, Nathalie |e investigator |4 oth | |
| 700 | 1 | |a Ouwehand, Willem |e investigator |4 oth | |
| 700 | 1 | |a Penkett, Christopher |e investigator |4 oth | |
| 700 | 1 | |a Raymond, F Lucy |e investigator |4 oth | |
| 700 | 1 | |a Stirrups, Kathleen |e investigator |4 oth | |
| 700 | 1 | |a Veltman, Marijke |e investigator |4 oth | |
| 700 | 1 | |a Young, Tim |e investigator |4 oth | |
| 700 | 1 | |a Brown, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Clements-Brod, Naomi |e investigator |4 oth | |
| 700 | 1 | |a Davis, John |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 43(2023), 7 vom: 17. Okt., Seite 1611-1622 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:7 |g day:17 |g month:10 |g pages:1611-1622 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-023-01530-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 7 |b 17 |c 10 |h 1611-1622 | ||